SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Dickman Paul W.)
 

Sökning: WFRF:(Dickman Paul W.) > Estimating the cure...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003198naa a2200445 4500
001oai:DiVA.org:uu-224590
003SwePub
008140514s2014 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:128643879
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2245902 URI
024a https://doi.org/10.1016/j.canep.2013.12.0062 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1286438792 URI
040 a (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Andersson, Therese M. -L.u Karolinska Institutet4 aut
2451 0a Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival :b A population-based study
264 1b Elsevier BV,c 2014
338 a print2 rdacarrier
520 a Objectives: A large proportion of patients with cutaneous malignant melanoma (CMM) do not experience excess mortality due to their disease. This group of patients is referred to as the cure proportion. Few studies have examined the possibility of cure for CMM. The aim of this study was to estimate the cure proportion of patients with CMM in a Swedish population. Methods: We undertook a population-based study of 5850 CMM patients in two Swedish health care regions during 1996-2005. We used flexible parametric cure models to estimate cure proportions and median survival times (MSTs) of uncured by stage, sex, age and anatomical site. Results: Disease stage at diagnosis was the most important factor for the probability of cure, with a cure proportion of approximately 1.0 for stage IA. While the probability of cure decreased with older age, the influence of age was smaller on the MST of uncured. Differences in prognosis between males and females were mainly attributed to differences in cure as opposed to differences in MST of uncured. Conclusions: This population-based study showed approximately 100% cure among stage IA disease. Almost 50% of patients had stage IA disease and the high cure proportion for this large patient group is reassuring.
653 a Malignant melanoma
653 a Survival
653 a Cure
653 a Population-based
653 a Flexible parametric model
653 a Relative survival
700a Eriksson, Hannau Karolinska Institutet4 aut
700a Hansson, Johanu Karolinska Institutet4 aut
700a Mansson-Brahme, Evau Karolinska Institutet4 aut
700a Dickman, Paul W.u Karolinska Institutet4 aut
700a Eloranta, Sandrau Karolinska Institutet4 aut
700a Lambe, Matsu Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)4 aut
700a Lambert, Paul C.u Karolinska Institutet4 aut
710a Karolinska Institutetb Uppsala kliniska forskningscentrum (UCR)4 org
773t Cancer Epidemiologyd : Elsevier BVg 38:1, s. 93-99q 38:1<93-99x 1877-7821x 1877-783X
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-224590
8564 8u https://doi.org/10.1016/j.canep.2013.12.006
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:128643879

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy